CLINICAL TRIAL
Published on 18 Oct 2022
A phase II study of buparlisib in relapsed or refractory thymomas

doi 10.3389/fonc.2022.891383
- 1,603 views
- 13 citations
19k
Total downloads
78k
Total views and downloads
CLINICAL TRIAL
Published on 18 Oct 2022
ORIGINAL RESEARCH
Published on 08 Jul 2022
SYSTEMATIC REVIEW
Published on 24 Jun 2022
ORIGINAL RESEARCH
Published on 06 Jun 2022
ORIGINAL RESEARCH
Published on 13 May 2022
REVIEW
Published on 08 Apr 2022
ORIGINAL RESEARCH
Published on 15 Mar 2022
ORIGINAL RESEARCH
Published on 18 Feb 2022
ORIGINAL RESEARCH
Published on 07 Feb 2022
ORIGINAL RESEARCH
Published on 25 Jan 2022
CASE REPORT
Published on 20 Jan 2022
ORIGINAL RESEARCH
Published on 14 Jan 2022